同有科技(300302.SZ):湖南同有簽署國有建設用地使用權出讓合同
格隆匯10月13日丨同有科技(300302.SZ)公佈,公司全資子公司湖南同有飛驥科技有限公司(以下簡稱“湖南同有”)根據長沙市國有建設用地使用權網上掛牌出讓公告(2020.08.19)的相關要求,於2020年9月23日以2673萬元競得[2020]長沙市070號地塊國有建設用地使用權。
近日,湖南同有與長沙市自然資源和規劃局就上述地塊簽訂了《國有建設用地使用權出讓合同》。公司本次取得的前述國有建設用地使用權,將用於建設規模化的存儲產業園,促進存儲底層生態融合,實現製造智能化、體系化、規模化,助力公司研發、生產實力全面升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.